Miromatrix Medical
MIRO | NASDAQ
$3.39
+$0.02 (+0.59%)
At close: Dec 12, 2023, 04:00 PM ET
+0.59%
(1D)Rating
Key Statistics
Market Data
Market Cap $92.95M
1D Range
3.36 3.53
52W Range
0.91 4.35
Valuation (TTM)
PE -3
PB 5.98
EV/EBITDA -3.06
Valuation (NTM)
Forward PE N/A
Forward PEG -0.12
Price Target $9.00
Cash Flow
FCF Yield -26.4%
SBC Adj. FCF Yield -27.7%
SBC Impact -5.0%
Margins
Gross Margin 47.6%
Operating Margin -2973.2%
FCF Margin -2562.6%
Growth (CAGR)
Revenue 3Y | 5Y 212.7% |
N/A
Dil EPS 3Y | 5Y -27.3% |
N/A
FCF 3Y | 5Y -29.4% |
N/A
Returns
ROA -86.3%
ROE -74.8%
ROIC -100.0%
Financial Health
Net Cash
$12.84M
Current Ratio 5.52
Interest Coverage -633.66
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary p...
Sector Healthcare
Industry Biotechnology
Employees 76
IPO Date Jun 24, 2021
Website www.miromatrix.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove MIRO